Dimethyl (2-oxo-4-phenylbutyl)phosphonate

We are Dimethyl (2-oxo-4-phenylbutyl)phosphonate CAS:41162-19-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Dimethyl (2-oxo-4-phenylbutyl)phosphonate
CAS.NO:41162-19-0
Synonyms:Dimethyl (2-oxo-4-phenylbutyl)phosphonate
1-dimethoxyphosphoryl-4-phenylbutan-2-one
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 362.7±25.0 °C at 760 mmHg
Melting Point 120-122 (0.5 MMHG)ºC
Molecular Formula C12H17O4P
Molecular Weight 256.235
Flash Point 186.8±43.5 °C
Vapour Pressure 0.0±0.8 mmHg at 25°C
Index of Refraction 1.494
 
Specification:
Appearance:Light yellow liquid
Assay:≥85.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Bimatoprost(CAS:155206-00-1) and Latanoprost(CAS:130209-82-4).

Dimethyl (2-oxo-4-phenylbutyl)phosphonate


Related News: “Once these risks have been identified then a project team can be put together combining the necessary expertise to provide the integrated services and tailored support to ensure continuity of supply from beginning to end.”2-metoxi-6-metilpiridina CAS:63071-03-4 The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.L-CISTEINA HCL H2O CAS:7048-04-6 Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.(3S)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]oxolane The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.

Related Products
Product Name
tetradecane-1-thiol View Details
5-Methoxy-2-methyl-1H-indole View Details
2-Chloro-6-fluorotoluene View Details
1-(2-chloro-4-hydroxyphenyl)-3-cyclopropylurea manufacturer L-tert-Leucine methyl ester hydrochloride manufacturer 1-(2′-Chloro-5′-sulfophenyl)-3-methyl-5-pyrazolone manufacturer N-Cbz-N-methyl-L-valine manufacturer 1-Pentanethiol manufacturer